Opiant Pharmaceuticals Revenue and Competitors

Santa Monica,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Opiant Pharmaceuticals's estimated annual revenue is currently $4.8M per year.(i)
  • Opiant Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Opiant Pharmaceuticals has 24 Employees.(i)
  • Opiant Pharmaceuticals grew their employee count by -59% last year.

Opiant Pharmaceuticals's People

NameTitleEmail/Phone
1
EVP, Corporate Development and General CounselReveal Email/Phone
2
VP Communications and Investor RelationsReveal Email/Phone
3
Associate Director, Project ManagementReveal Email/Phone
4
Drug Development Associate DirectorReveal Email/Phone
5
Chief Development OfficerReveal Email/Phone
6
Chief Commercial OfficerReveal Email/Phone
7
Associate Director, Project ManagementReveal Email/Phone
8
Director, Supply ChainReveal Email/Phone
9
Clinical Trial ManagerReveal Email/Phone
10
Clinical Trial ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Opiant Pharmaceuticals?

Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. Stay up to date with news on business news, results, and product innovation updates by following our page and visiting our site www.Opiant.com

keywords:N/A

N/A

Total Funding

24

Number of Employees

$4.8M

Revenue (est)

-59%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Opiant Pharmaceuticals News

2022-04-17 - Opiant Pharmaceuticals (NASDAQ:OPNT) Stock Rating ...

Opiant Pharmaceuticals, Inc is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and...

2022-03-22 - Opiant Pharmaceuticals Announces Fourth Quarter and Full ...

About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M249%N/A
#2
N/A24-4%N/A
#3
$3M244%$21M
#4
$2.8M249%N/A
#5
$4.5M24-17%N/A